Delivery Order SPE2DR25D1053-SPE2DR26FV218
Award Date 1/5/26
Potential Completion Date 1/6/26
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,735.52 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $24,085.78 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye (pancrelipase) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price, competitively awarded delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Pertzye (pancrelipase) capsules—16,000 units in 100-count bottles. This competitive, non-set-aside contract has a ceiling value of $5,750.73 and a firm fixed price structure, with an ultimate completion date of October 29, 2025. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 16,000 units of PERTZYE DR, a prescription medication, with a potential value of $5,826.78 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and it is not designated as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp on January 2, 2026, for pharmaceutical products and supplies supporting federal medical procurement needs. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999.999 billion and extends through December...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $738,830.10 to AmerisourceBergen Drug Corp on September 6, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's position as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on December 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 19, 2025, valued at $3,708.00 with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $169,397.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for pharmaceutical products and medical supplies. This is an unset-aside, competitively awarded delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at the contractor's corporate office location...